We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Researchers Use CRISPR To Correct Mutation in Duchenne Muscular Dystrophy Model

News   Sep 17, 2019 | Original story from the University of Missouri School of Medicine

 
Researchers Use CRISPR To Correct Mutation in Duchenne Muscular Dystrophy Model
 
 
Advertisement
 

RELATED ARTICLES

CROs SIRO and AZIDUS Partner To Expand Their Services

News

Clinpharm Private Limited partners with Azidus to strategically expand combined services offerings and avail access to an expanded client base for technical requisites of pharmaceutical and biotechnology industries.

READ MORE

mRNA COVID-19 Vaccine Is Well-Tolerated and Generates Immune Response

News

A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults.

READ MORE

Exploring the Landscape of Pancreatic Tumors With Single-Cell RNA Sequencing

News

A team of researchers has described the individual cells that comprise the pancreatic cancer microenvironment, a critical step in devising new treatment options for patients with this aggressive and difficult-to-treat disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE